Načítá se...
Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing
Biological fluid-based noninvasive biomarker assays for monitoring and diagnosing disease are clinically powerful. A major technical hurdle for developing these assays is the requirement of high analytical sensitivity so that biomarkers present at very low levels can be consistently detected. In the...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3806441/ https://ncbi.nlm.nih.gov/pubmed/24199178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S32736 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|